Cardiac complications and manifestations of chemotherapy for cancer

Heart. 2014 Jul;100(14):1133-40. doi: 10.1136/heartjnl-2013-303713. Epub 2013 Dec 10.

Authors

Muhammed Zeeshan Khawaja¹, Catherine Cafferkey², Ronak Rajani³, Simon Redwood¹, David Cunningham²

Affiliations

¹ Cardiovascular Division, British Heart Foundation Centre of Excellence, The Rayne Institute, King's College London, St Thomas' Hospital, London, UK Department of Cardiology, Guy's & St Thomas' NHS Foundation Trust, London, UK.
² Department of Medical Oncology, Royal Marsden NHS Foundation Trust, London, UK.
³ Department of Cardiology, Guy's & St Thomas' NHS Foundation Trust, London, UK.

PMID: 24326899
DOI: 10.1136/heartjnl-2013-303713

No abstract available

Keywords: Cardio-Oncology; Cardiomyopathy; Cardiotoxicity; Chemotherapy; Heart Failure.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Angiogenesis Inhibitors / adverse effects
Anthracyclines / adverse effects
Antibodies, Monoclonal, Humanized / adverse effects
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Heart Diseases / chemically induced*
Heart Diseases / prevention & control
Heart Failure / chemically induced
Humans
Hypertension / chemically induced
Neoplasms / drug therapy*
Risk Assessment
Risk Factors

Substances

Angiogenesis Inhibitors
Anthracyclines
Antibodies, Monoclonal, Humanized

Grants and funding

FS/12/15/29380/British Heart Foundation/United Kingdom